Skip to main content

Advertisement

Log in

Systematic review of in vivo microorganisms imaging with labeled vitamins, bacteriophages and oligomers

  • Review Article
  • Published:
Clinical and Translational Imaging Aims and scope Submit manuscript

Abstract

Infection is always accompanied by inflammation and the real challenge is the ability to discriminate between infection and inflammation, this represents the “condicio sine qua non” for choosing the correct therapy. The role of the nuclear physician should be that to choose the appropriate radiopharmaceutical for each patient’s condition, to administer the imaging agent, to acquire scintigraphic images, and finally to report a diagnosis or a treatment response. Unfortunately, all the radiopharmaceuticals commercially available are nowadays not able to recognize directly the presence of bacteria, for this reason there are some radiopharmaceuticals that are under experimental evaluation, in this review bacterial growth factors (Biotin and Cyanocobalamin), bacteriophages and phosphorodiamidate morpholino (MORF) will be described. A systematic review of the literature of reported diagnostic accuracy of labeled biotin scintigraphy in detection of infection diseases, as well as a review of the preclinical studies with labeled bacteriophages and phosphorodiamidate morpholino for bacteria-targeted imaging, are presented. The results of 7 clinical studies carried out from 1996 to 2010 using labeled Biotin scintigraphy in patients with bone infection indicate a pooled sensitivity of 95.4 % and specificity of 92.8 %. Scintigraphic images of preclinical studies with labeled bacteriophages and MORF showed high diagnostic accuracy in the diagnosis of infection. Labeled biotin, tested in a relatively small patients group (n = 357), still need further studies to reach a significative level of evidence. All the other described radiopharmaceuticals need further studies to allow their use in patients for finally distinguishing infection from sterile inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. OCEBM Levels of Evidence Working Group (2016) The Oxford 2011 levels of evidence. Oxford Center for evidence-based medicine. http://www.cebm.net/index.aspx?0=5653

  2. Erba PA, Cataldi AG, Tascini C, Leonildi A, Manfredi C, Mariani G, Lazzeri E (2010) 111In-DTPA-Biotin uptake by Staphylococcus aureus. Nucl Med Comm 31:994–997

    Article  CAS  Google Scholar 

  3. Hnatowich DJ, Virzi F, Rusckowski M (1987) Investigations of avidin and biotin for imaging applications. J Nucl Med 28:1294–1302

    CAS  PubMed  Google Scholar 

  4. Rusckowski M, Fritz B, Hnatowich DJ (1992) Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin. J Nucl Med 33:1810–1815

    CAS  PubMed  Google Scholar 

  5. Fogarasi M, Pullman J, Winnard P Jr, Hnatowich DJ, Rusckowski M (1999) Pretargeting of bacterial endocarditis in rats with streptavidin and 111In-labeled biotin. J Nucl Med 40:484–490

    CAS  PubMed  Google Scholar 

  6. Chiesa R, Melissano G, Castellano R, Fernandez Zamora C, Astore D, Samuel A, Paganelli G, Fazio F, Grossi A (1995) Avidin and 111In-labelled biotin scan: a new radioisotopic method for localising vascular graft infection. Eur J Vasc Endovasc Surg 10:405–414

    Article  CAS  PubMed  Google Scholar 

  7. Samuel A, Paganelli G, Chiesa R, Sudati F, Calvitto M, Melissano G, Grossi A, Fazio F (1996) Detection of prosthetic vascular graft infection using avidin/indium-111-biotin scintigraphy. J Nucl Med 37:55–61

    CAS  PubMed  Google Scholar 

  8. Rusckowski M, Paganelli G, Hnatowich DJ, Magnani P, Virzi F, Fogarasi M, DiLeo C, Sudati F, Fazio F (1996) Imaging osteomyelitis with streptavidin and indium-111-labeled biotin. J Nucl Med 37:1655–1662

    CAS  PubMed  Google Scholar 

  9. Lazzeri E, Manca M, Molea N, Marchetti S, Consoli V, Bodei L, Bianchi R, Chinol M, Paganelli G, Mariani G (1999) Clinical validation of the avidin/indium-111 biotin approach for imaging infection/inflammation in orthopaedic patients. Eur J Nucl Med 26:606–614

    Article  CAS  PubMed  Google Scholar 

  10. Lazzeri E, Pauwels EK, Erba PA, Volterrani D, Manca M, Bodei L, Trippi D, Bottoni A, Cristofani R, Consoli V, Palestro CJ, Mariani G (2004) Clinical feasibility of two-step streptavidin/111In-biotin scintigraphy in patients with suspected vertebral osteomyelitis. Eur J Nucl Med Mol Imaging 31:1505–1511

    Article  PubMed  Google Scholar 

  11. Lazzeri E, Erba P, Perri M, Tascini C, Doria R, Giorgetti J, Mariani G (2008) Scintigraphic imaging of vertebral osteomyelitis with 111In-Biotin. Spine 33:198–204

    Article  Google Scholar 

  12. Lazzeri E, Erba P, Perri M, Doria R, Tascini C, Mariani G (2010) Clinical impact of SPECT/CT with In-111 biotin on the management of patients with suspected spine infection. Clin Nucl Med 35:12–17

    Article  PubMed  Google Scholar 

  13. Baldoni D, Waibel R, Bläuenstein P, Galli F, Iodice V, Signore A, Schibli R, Trampuz A (2015) Evaluation of a novel Tc-99 m labelled vitamin B12 derivative for targeting Escherichia coli and Staphylococcus aureus in vitro and in an experimental foreign-body infection model. Mol Imaging Biol 17:829–837

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Drulis-Kawa Z, Majkowska-Skrobek G, Maciejewska B, Delattre AS, Lavigne R (2012) Learning from bacteriophages—advantages and limitations of phage and phage-encoded protein applications. Curr Protein Pept Sci 13:699–722

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Rusckowski M, Gupta S, Liu G, Dou S, Hnatowich DJ (2004) Investigations of a 99mTc-labeled bacteriophage as a potential infection-specific imaging agent. J Nucl Med 45:1201–1208

    CAS  PubMed  Google Scholar 

  16. Mathur MD, Vidhani S, Mehndiratta PL (2003) Bacteriophage therapy: an alternative to conventional antibiotics. J Assoc Phys India 51:593–596

    CAS  Google Scholar 

  17. Merril CR, Scholl D, Adhya SL (2003) The prospect for bacteriophage therapy in Western medicine. Nat Rev Drug Discovery 2:489–497

    Article  CAS  PubMed  Google Scholar 

  18. Rusckowski M, Gupta S, Liu G, Dou S, Hnatowich DJ (2008) Investigation of four (99m)Tc-labeled bacteriophages for infection-specific imaging. Nucl Med Biol 35:433–440

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Elena CM, Leticia F, Emilia T, Patricia E, Mariella T (2016) Evaluation of a labelled bacteriophage with 99mTc as a potential agent for infection diagnosis. Curr Radiopharm. Feb 15 [Epub ahead of print] PubMed PMID: 26876366

  20. Stahl DA, Flesher B, Mansfield HR, Montgomery L (1988) Use of phylogenetically based hybridization probes for studies of ruminal microbial ecology. Appl Environ Microbiol 54:1079–1084

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Wang Y, Chen L, Liu X, Cheng D, Liu G, Liu Y, Dou S, Hnatowich DJ, Rusckowski M (2013) Detection of Aspergillus fumigatus pulmonary fungal infections in mice with (99m)Tc-labeled MORF oligomers targeting ribosomal RNA. Nucl Med Biol 40:89–96

    Article  PubMed  Google Scholar 

  22. Chen L, Wang Y, Cheng D, Liu X, Dou S, Liu G, Hnatowich DJ, Rusckowski M (2013) 99mTc-MORF oligomers specific for bacterial ribosomal RNA as potential specific infection imaging agents. Bioorgan Med Chem 21:6523–6530

    Article  CAS  Google Scholar 

  23. dos Santos SR, Rodrigues Correa C, Branco de Barros AL, Serakides R, Fernandes SO, Cardoso VN, de Andrade AS (2015) Identification of Staphylococcus aureus infection by aptamers directly radiolabeled with technetium-99m. Nucl Med Biol 42:292–298

    Article  PubMed  Google Scholar 

  24. Signore A, D’Alessandria C, Lazzeri E, Dierckx R (2008) Can we produce an image of bacteria with radiopharmaceuticals? Eur J Nucl Med Mol Imaging 35:1051–1055

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Claesener M, Breyholz HJ, Hermann S, Faust A, Wagner S, Schober O, Schäfers M, Kopka K (2012) Efficient synthesis of a fluorine-18 labeled biotin derivative. Nucl Med Biol 39:1189–1194

    Article  CAS  PubMed  Google Scholar 

  26. Shoup TM, Fischman AJ, Jaywook S, Babich JW, Strauss HW, Elmaleh DR (1994) Synthesis of fluorine-18-labeled biotin derivatives: biodistribution and infection localization J NucI Med 35:1685–1716

  27. Ho K (2001) Bacteriophage therapy for bacterial infections. Rekindling a memory from the pre-antibiotics era. Perspect Biol Med 44:1–16

    Article  CAS  PubMed  Google Scholar 

  28. Gijs M, Aerts A, Impens N, Baatout S, Luxen A (2016) Aptamers as radiopharmaceuticals for nuclear imaging and therapy. Nucl Med Biol Nucl Med Biol 43:253–271

    Article  CAS  PubMed  Google Scholar 

  29. Kim YS, Chung J, Song MY, Jurng J, Kim BC (2014) Aptamer cocktails: enhancement of sensing signals compared to single use of aptamers for detection of bacteria. Biosens Bioelectron 54:195–198

    Article  CAS  PubMed  Google Scholar 

  30. Dougherty CA, Cai W, Hong H (2015) Applications of aptamers in targeted imaging: state of the art. Curr Top Med Chem 15:1138–1152

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Lee JH, Shin SK, Jiang Y, Choi WH, Hong C, Kim DE, Lee MJ (2015) Facilitated Tau degradation by USP14 aptamers via enhanced proteasome activity. Sci Rep. doi:10.1038/srep10757

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elena Lazzeri.

Ethics declarations

Conflict of interest

Elena Lazzeri declares no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lazzeri, E. Systematic review of in vivo microorganisms imaging with labeled vitamins, bacteriophages and oligomers. Clin Transl Imaging 4, 265–272 (2016). https://doi.org/10.1007/s40336-016-0182-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40336-016-0182-y

Keywords

Navigation